Your browser doesn't support javascript.
loading
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial.
Schuler, M; Berardi, R; Lim, W-T; de Jonge, M; Bauer, T M; Azaro, A; Gottfried, M; Han, J-Y; Lee, D H; Wollner, M; Hong, D S; Vogel, A; Delmonte, A; Akimov, M; Ghebremariam, S; Cui, X; Nwana, N; Giovannini, M; Kim, T M.
Affiliation
  • Schuler M; Department of Medical Oncology, West German Cancer Center, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany. Electronic address: martin.schuler@uk-essen.de.
  • Berardi R; Clinica Oncologica, Università Politecnica delle Marche-Ospedali Riuniti, Ancona, Italy.
  • Lim WT; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • de Jonge M; Medical Oncology, Erasmus MC Cancer Center, Rotterdam, The Netherlands.
  • Bauer TM; Drug Development Unit, Sarah Cannon Research Institute, and Tennessee Oncology, PLCC, Nashville, USA.
  • Azaro A; Medical Oncology, Molecular Therapeutics Research Unit, Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Pharmacology Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Gottfried M; Department of Oncology, Oncology Institute of Meir Medical Center, Tel-Aviv, Israel.
  • Han JY; Center for Lung Cancer, National Cancer Center, Seoul.
  • Lee DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Wollner M; Thoracic Service Oncology Department, Rambam Health Care Campus, Haifa, Israel.
  • Hong DS; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, USA.
  • Vogel A; Gastroenterology, Hepatology, Endocrinology, Hannover Medical School, Hannover, Germany.
  • Delmonte A; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST), IRCCS, Meldola, Italy.
  • Akimov M; Oncology Global Development, Novartis Pharma AG, Basel, Switzerland.
  • Ghebremariam S; Oncology Global Development-BDM.
  • Cui X; Novartis Institutes for Biomedical Research.
  • Nwana N; Oncology Precision Medicine.
  • Giovannini M; Oncology Global Development, Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Kim TM; Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Ann Oncol ; 31(6): 789-797, 2020 06.
Article in En | MEDLINE | ID: mdl-32240796
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication: